Related Experiment Video
Updated: Nov 3, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
New variants of SARS-CoV-2
R Cantón, P De Lucas Ramos, A García-Botella
1Emilio Bouza, Servicio de Microbiología Clínica y Enfermedades Infecciosas del Hospital General Universitario Gregorio Marañón, Universidad Complutense. CIBERES. Ciber de Enfermedades Respiratorias. Madrid, Spain. emilio.bouza@gmail.com.
New SARS-CoV-2 variants like B.1.1.7 raise concerns about increased transmissibility and vaccine escape. Continued vaccination and containment measures are crucial to prevent further spread and potential future revaccinations.
Area of Science:
- Virology
- Epidemiology
- Public Health
Background:
- The emergence of SARS-CoV-2 variants, such as B.1.1.7, P.1, and B.1.351, is of significant concern.
- These variants may exhibit increased transmissibility, altered disease progression, and potential immune escape from existing vaccines.
- Variants of interest, including B.1.427, B.1.429, and B.1.617, are also monitored for their spread.
Purpose of the Study:
- To highlight the significance of monitoring and characterizing new SARS-CoV-2 variants.
- To discuss the implications of these variants on public health and vaccine efficacy.
- To emphasize the need for continued global efforts in controlling viral spread.
Main Methods:
- Whole genome sequencing is employed for the comprehensive characterization of SARS-CoV-2.
- Targeted sequencing strategies focusing on the spike gene are utilized for rapid detection.
- Epidemiological data and sanitary situations are considered in assessing variant dispersion.
Main Results:
- Several key SARS-CoV-2 variants of public health concern and interest have been identified globally.
- The spread of these variants is influenced by factors including infection rates, public health infrastructure, and control measures.
- The potential for immune escape necessitates ongoing surveillance and research.
Conclusions:
- Increased vaccination coverage worldwide and sustained epidemiological containment are essential to mitigate the emergence and spread of new SARS-CoV-2 variants.
- The possibility of requiring future revaccination campaigns against emerging variants cannot be ruled out.
- Continuous global collaboration and surveillance are vital in managing the evolving threat of SARS-CoV-2.
More Related Videos
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Viral Recombination
Viruses with RNA Genomes
Viral Mutations
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Subviral Agents

